Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

Welcome — one more step

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Ask Duki without the monthly limit — answers from the coverage, with sources
  • Save articles, synced between the web and the app
  • Every Not Everywhere story, no daily limit
  • How each newsroom worded the same event
  • Filing timeline and coverage breakdown
  • The whole archive, searchable
  • Unlimited newsroom, topic and people follows
  • The daily brief by email, in English or Hebrew

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Search stories

Type at least two characters. Results come from every newsroom baba reads.

to move · to open · esc to close

Live Terminal

Sign in to baba News

Sign in to keep asking. News Plus removes the daily limit.

or use an email code

Keep the whole picture

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Ask Duki without the monthly limit — answers from the coverage, with sources
  • Save articles, synced between the web and the app
  • Every Not Everywhere story, no daily limit
  • How each newsroom worded the same event
  • Filing timeline and coverage breakdown
  • The whole archive, searchable
  • Unlimited newsroom, topic and people follows
  • The daily brief by email, in English or Hebrew

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Compare full coverage across 2 outlets

Sign in to baba News

Sign in to save this article and find it on your phone.

or use an email code

By אור הדר
Health14:01 · 3h ago

Health Ministry Reports Flaw in Genetic Testing Kit for BRCA1 Gene

YnetCenter
Translated & summarized from Ynet by baba
The story · English

Israel's Ministry of Health announced on Sunday that a malfunction has been reported in a genetic testing kit for the BRCA1 gene manufactured by the company Gemidor. The issue raises concerns about the possibility of receiving false negative results.

Following the report, the ministry reviewed results from over 90,000 individuals tested with the faulty kit. Approximately 100 samples have been identified as potentially having received an incorrect negative result. Gemidor has since rectified the technical problem with the kit.

Genetic institutes and laboratories that used the defective kit are contacting affected individuals. Those whose results are deemed questionable may be asked to provide an additional blood sample for retesting.

Read the original at Ynet
Full coverage · 2 outlets
100% centerFirst: Hamal · 3h ago

The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.

Center 2
Related stories · 5

Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.

Open the live terminal